University of California San Francisco

Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi. (34076666)

Robertson SJ, Orme L, Teixeira R, Shamassi M, Newell F, Patch AM, Yeh I, Gard G, Wilmott J, Jackett L, LeBoit P, Fellowes A, MacArthur G, Fox S, Hayward NK, Bastian B, Scolyer R, Waddell N, Penington A, Shackleton M PMID: 34076666

Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi. (34076666)

Robertson SJ, Orme L, Teixeira R, Shamassi M, Newell F, Patch AM, Yeh I, Gard G, Wilmott J, Jackett L, LeBoit P, Fellowes A, MacArthur G, Fox S, Hayward NK, Bastian B, Scolyer R, Waddell N, Penington A, Shackleton M PMID: 34076666

Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi. (34076666)

Robertson SJ, Orme L, Teixeira R, Shamassi M, Newell F, Patch AM, Yeh I, Gard G, Wilmott J, Jackett L, LeBoit P, Fellowes A, MacArthur G, Fox S, Hayward NK, Bastian B, Scolyer R, Waddell N, Penington A, Shackleton M PMID: 34076666

Two Trajectories to Melanoma on the Hands and Feet. (33978680)

Shain AH PMID: 33978680

UVB mutagenesis differs in Nras- and Braf-mutant mouse models of melanoma. (34210801)

Bowman RL, Hennessey RC, Weiss TJ, Tallman DA, Crawford ER, Murphy BM, Webb A, Zhang S, La Perle KM, Burd CJ, Levine RL, Shain AH, Burd CE PMID: 34210801

Quantitative readability analysis of online patient educational materials for dermatofibrosarcoma protuberans. (34165781)

Kirchner A, Patel M, Kulkarni V, Usman A, Lee EY PMID: 34165781

A role for IL-33-activated ILC2s in eosinophilic vasculitis. (33974563)

Kotas ME, Dion J, Van Dyken S, Ricardo-Gonzalez RR, Danel CJ, Taill? C, Mouthon L, Locksley RM, Terrier B PMID: 33974563

Phenotypic overlap between atopic dermatitis and autism. (34157971)

Shin KO, Crumrine DA, Kim S, Lee Y, Kim B, Abuabara K, Park C, Uchida Y, Wakefield JS, Meyer JM, Jeong S, Park BD, Park K, Elias PM PMID: 34157971

Cutaneous body image: A window into the adolescent experience of dermatologic disease. (34152034)

Provini LE, Omandac VT, Bahrani E, Aghdasi C, Cordoro KM PMID: 34152034

Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline. (35756599)

Bui A, Liu J, Hong J, Hadeler E, Mosca M, Brownstone N, Liao W PMID: 35756599